There are 2789 resources available
466P - Landscape of HER2 alterations in 5786 Chinese patients with colorectal cancer
Presenter: Xiaoyun Li
Session: ePoster Display
467P - Monocyte to red blood cells ratio (MRR): an innovative haematologic prognostic parameter in FOLFIRI-aflibercept treated patients: A subgroup analysis from the DISTINCTIVE trial
Presenter: Eleonora Lai
Session: ePoster Display
468P - Prognostic role of aspartate aminotransferase-to-alanine aminotransferase ratio and lactate dehydrogenase levels in resectable colorectal cancer
Presenter: Ma Yifei
Session: ePoster Display
469P - Potential emergent role of liquid biopsy in clinical practice in metastatic colorectal cancer (mCRC) treatment
Presenter: Valeria Zurlo
Session: ePoster Display
Resources:
Abstract
470P - Genomic landscape and its correlations with immunotherapy-related biomarkers in Chinese colorectal cancer patients
Presenter: Xiao Zheng
Session: ePoster Display
Resources:
Abstract
471P - Prognostic role of preoperative direct bilirubin-to-indirect bilirubin ratio and neutrophils-to-lymphocytes in resectable colorectal cancer
Presenter: Yifei Ma
Session: ePoster Display
472P - Characterizing the anal microbiome in proximal versus distal colorectal cancer
Presenter: Soham Ali
Session: ePoster Display
473P - A phase I study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in patients with advanced solid tumors including colorectal cancer (CRC)
Presenter: Akihito Kawazoe
Session: ePoster Display
501P - Analysis of clinical characteristics and survival trends of patients with metastatic colorectal cancer (mCRC) receiving ≥3 lines of treatment
Presenter: Marianela Bringas Beranek
Session: ePoster Display
425P - Cetuximab could be administered once every two weeks instead of once weekly
Presenter: sarah Lobet
Session: ePoster Display